EX-23.1 3 tcon-ex23_1.htm EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

|  |  | (1) Registration Statement (Form S-8 No. 333-270372) pertaining to the Amended and Restated 2015 Equity Incentive Plan and Amended and Restated 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (2) Registration Statement (Form S-8 No. 333-263591) pertaining to the Amended and Restated 2015 Equity Incentive Plan and Amended and Restated 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (3) Registration Statement (Form S-8 No. 333-258077) pertaining to the Amended and Restated 2015 Equity Incentive Plan of TRACON Pharmaceuticals, Inc., (4) Registration Statement (Form S-8 No. 333-253546) pertaining to the 2015 Equity Incentive Plan and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (5) Registration Statement (Form S-8 No. 333-236732) pertaining to the 2015 Equity Incentive Plan and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (6) Registration Statement (Form S-8 No. 333-229988) pertaining to the 2015 Equity Incentive Plan and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (7) Registration Statement (Form S-8 No. 333-223333) pertaining to the 2015 Equity Incentive Plan and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (8) Registration Statement (Form S-8 No. 333-216347) pertaining to the 2015 Equity Incentive Plan and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (9) Registration Statement (Form S-8 No. 333-209592) pertaining to the 2015 Equity Incentive Plan and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (10) Registration Statement (Form S-8 No. 333-201808) pertaining to the 2011 Equity Incentive Plan, 2015 Equity Incentive Plan and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (11) Registration Statement (Form S-1 No. 333-272100) of TRACON Pharmaceuticals, Inc., (12) Registration Statement (Form S-1 No. 333-239574) of TRACON Pharmaceuticals, Inc., (13) Registration Statement (Form S-1 No. 333-234651) of TRACON Pharmaceuticals, Inc., (14) Registration Statement (Form S-3 No. 333-270589) of TRACON Pharmaceuticals, Inc., (15) Registration Statement (Form S-3 No. 333-263590) of TRACON Pharmaceuticals, Inc., (16) Registration Statement (Form S-3 No. 333-248593) of TRACON Pharmaceuticals, Inc., and (17) Registration Statement (Form S-3 No. 333-224809) of TRACON Pharmaceuticals, Inc.

of our report dated March 5, 2024, with respect to the consolidated financial statements of TRACON Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of TRACON Pharmaceuticals, Inc. for the year ended December 31, 2023.

| /s/ Ernst & Young LLP

San Diego, California

March 5, 2024